Results: 5000
Novartis Issues Voluntary Nationwide Recall of One Lot of Cyclosporine Oral Solution.
- Published in:
- ONS Voice, 2023, p. 2
- Publication type:
- Article
FDA Approves Melphalan as a Liver-Directed Treatment for Uveal Melanoma.
- Published in:
- ONS Voice, 2023, p. 1
- Publication type:
- Article
FDA Grants Accelerated Approval to Talquetamab-Tgvs for Relapsed or Refractory Multiple Myeloma.
- Published in:
- ONS Voice, 2023, p. 1
- Publication type:
- Article
FDA Approves Trifluridine and Tipiracil With Bevacizumab for Previously Treated Metastatic Colorectal Cancer.
- Published in:
- ONS Voice, 2023, p. 1
- Publication type:
- Article
FDA Approves Quizartinib for Newly Diagnosed Acute Myeloid Leukemia.
- Published in:
- ONS Voice, 2023, p. 1
- Publication type:
- Article
FDA Approves Talazoparib With Enzalutamide for HRR Gene--Variant Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- ONS Voice, 2023, p. 2
- Publication type:
- Article
The Harvard Drug Group, LLC, Issues Voluntary Nationwide Recall of Dronabinol Capsules, USP, 2.5 mg, and Ziprasidone Hydrochloride Capsules, 20 mg, Because of Label Mix-Up.
- Published in:
- ONS Voice, 2023, p. 1
- Publication type:
- Article
Comparative Evaluation of Regain of Consciousness in Dexmedetomidine–Propofol versus Ketamine–Propofol in the Pediatric Cardiac Catheterization Procedure under Sedation using BIS Monitoring: A Randomized Prospective Study.
- Published in:
- Annals of Cardiac Anaesthesia, 2025, v. 28, n. 1, p. 33, doi. 10.4103/aca.aca_19_24
- By:
- Publication type:
- Article
Machine learning model to predict the adherence of tuberculosis patients experiencing increased levels of liver enzymes in Indonesia.
- Published in:
- PLoS ONE, 2025, v. 20, n. 1, p. 1, doi. 10.1371/journal.pone.0315912
- By:
- Publication type:
- Article
Endocrine Adverse Events in Patients Treated with Immune Checkpoint Inhibitors: A Comprehensive Analysis.
- Published in:
- Medicina (1010660X), 2025, v. 61, n. 1, p. 123, doi. 10.3390/medicina61010123
- By:
- Publication type:
- Article
Underreporting Supplements: A Case of Drug-induced Liver Injury Due to a Testosterone Booster.
- Published in:
- Military Medicine, 2025, v. 190, n. 1/2, p. e453, doi. 10.1093/milmed/usae136
- By:
- Publication type:
- Article
A Case of Multidrug-Resistant Tuberculosis in an Active Duty Military Health Care Worker.
- Published in:
- Military Medicine, 2025, v. 190, n. 1/2, p. e448, doi. 10.1093/milmed/usae104
- By:
- Publication type:
- Article
Initial Empirical Antibiotic Treatment in Patients with COVID-19 is Associated with Excess Adverse Drug Reactions without Clinical Benefit.
- Published in:
- Turkish Journal of Pharmaceutical Sciences, 2024, v. 21, n. 6, p. 489, doi. 10.4274/tjps.galenos.2023.44675
- By:
- Publication type:
- Article
Safety assessment of tolvaptan: real-world adverse event analysis using the FAERS database.
- Published in:
- Frontiers in Pharmacology, 2025, p. 1, doi. 10.3389/fphar.2024.1509310
- By:
- Publication type:
- Article
Adverse drug events (ADEs) risk signal mining related to eculizumab based on the FARES database.
- Published in:
- Frontiers in Pharmacology, 2025, p. 1, doi. 10.3389/fphar.2024.1440907
- By:
- Publication type:
- Article
Eosinophil is a predictor of severe immune-related adverse events induced by ipilimumab plus nivolumab therapy in patients with renal cell carcinoma: a retrospective multicenter cohort study.
- Published in:
- Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2024.1483956
- By:
- Publication type:
- Article
Antiviral and Monoclonal Antibody Combination Therapy in Haematological Patients in the Omicron Era.
- Published in:
- Mediterranean Journal of Hematology & Infectious Diseases, 2024, v. 16, n. 1, p. 1, doi. 10.4084/MJHID.2024.043
- By:
- Publication type:
- Article
Radiological and Pathological Analysis of Pembrolizumab-Associated Lung Lesions: Diagnostic Challenges and Management.
- Published in:
- 2025
- By:
- Publication type:
- Case Study
Drug-induced subacute cutaneous lupus erythematous from cenobamate: case presentation and review of the literature.
- Published in:
- Dermatology Online Journal, 2024, v. 30, n. 6, p. 1, doi. 10.5070/D330664689
- By:
- Publication type:
- Article
Increased PD-1 expression in livers associated with PD-1-antibody-induced hepatotoxicity.
- Published in:
- BMC Immunology, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s12865-025-00682-y
- By:
- Publication type:
- Article
Should We Start Prescribing Azithromycin over Clindamycin?
- Published in:
- Ontario Dentist, 2024, n. 233, p. 20
- By:
- Publication type:
- Article
Safety of combined drug use in patients with cardiovascular and cerebrovascular diseases: an analysis based on the spontaneous reporting database of adverse drug reactions in Hubei Province.
- Published in:
- Frontiers in Pharmacology, 2025, p. 1, doi. 10.3389/fphar.2024.1451713
- By:
- Publication type:
- Article
An anonymized, de-identified registry study protocol to determine the effectiveness and safety of weight loss with enavogliflozin in patients with type 2 diabetes mellitus.
- Published in:
- PLoS ONE, 2025, v. 20, n. 1, p. 1, doi. 10.1371/journal.pone.0315603
- By:
- Publication type:
- Article
Eventos adversos notificados ao sistema nacional de notificação (VigiMed) envolvendo medicamentos antineoplásicos no Brasil.
- Published in:
- Saúde e Pesquisa, 2024, v. 17, n. 4, p. 108, doi. 10.17765/2176-9206.2024v17n4.e12816
- By:
- Publication type:
- Article
Intravenous fosphenytoin therapy for the rescue of acute trigeminal neuralgia crisis in pre- and post-neurosurgical patients: a retrospective observational study.
- Published in:
- Frontiers in Neurology, 2025, p. 1, doi. 10.3389/fneur.2024.1493274
- By:
- Publication type:
- Article
Hepatotoxicity of statins: a real-world study based on the US Food and Drug Administration Adverse Event Reporting System database.
- Published in:
- Frontiers in Pharmacology, 2025, p. 1, doi. 10.3389/fphar.2024.1502791
- By:
- Publication type:
- Article
LC-MS/MS assisted pharmacokinetic and tissue distribution study of ropivacaine and 3-OH-ropivacaine on rats after plane block anesthesia.
- Published in:
- Frontiers in Pharmacology, 2025, p. 1, doi. 10.3389/fphar.2024.1494646
- By:
- Publication type:
- Article
Comprehensive analysis of adverse events associated with onasemnogene abeparvovec (Zolgensma) in spinal muscular atrophy patients: insights from FAERS database.
- Published in:
- Frontiers in Pharmacology, 2025, p. 1, doi. 10.3389/fphar.2024.1475884
- By:
- Publication type:
- Article
Long-Term Safety and Effectiveness of Canakinumab in Patients with MKD/HIDS: Interim Analysis of the RELIANCE Registry.
- Published in:
- Rheumatology & Therapy, 2025, v. 12, n. 1, p. 137, doi. 10.1007/s40744-024-00733-7
- By:
- Publication type:
- Article
Safety evaluation of medroxyprogesterone acetate: a pharmacovigilance analysis using FDA adverse event reporting system data.
- Published in:
- Frontiers in Pharmacology, 2025, p. 1, doi. 10.3389/fphar.2024.1491032
- By:
- Publication type:
- Article
Drug-induced urinary retention: a real-world pharmacovigilance study using FDA and Canada vigilance databases.
- Published in:
- Frontiers in Pharmacology, 2025, p. 1, doi. 10.3389/fphar.2024.1466875
- By:
- Publication type:
- Article
Severe cutaneous adverse drug reactions: A search for the culprit in a retrospective study of 107 patients.
- Published in:
- Our Dermatology Online / Nasza Dermatologia Online, 2025, v. 16, n. 1, p. 43, doi. 10.7241/ourd.20251.6
- By:
- Publication type:
- Article
Eritema medicamentoso pigmentado fijo por etoricoxib: reporte de caso.
- Published in:
- Iatreia, 2025, v. 38, n. 1, p. 173, doi. 10.17533/udea.iatreia.280
- By:
- Publication type:
- Article
Role of herbal compounds to treat Drug-Induced Liver Injury (DILI).
- Published in:
- Allelopathy Journal, 2025, v. 64, n. 1, p. 47, doi. 10.26651/allelo.j/2025-64-1-1517
- By:
- Publication type:
- Article
Effect of WeChat-Based Medication Guidance on Symptoms and Serological Parameters in Children with Mycoplasma Pneumoniae.
- Published in:
- Alternative Therapies in Health & Medicine, 2024, v. 30, n. 12, p. 100
- By:
- Publication type:
- Article
Polypharmacy and anticholinergic burden scales in older adults: a cross-sectional study among psychiatric outpatients in a tertiary care hospital.
- Published in:
- BMC Geriatrics, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12877-024-05584-z
- By:
- Publication type:
- Article
Assessment of etiology and pharmacotherapy of patients with anemia in chronic myeloid leukemia: Challenges and opportunities in a tertiary care government hospital.
- Published in:
- National Journal of Physiology, Pharmacy & Pharmacology, 2024, v. 14, n. 12, p. 2525, doi. 10.5455/NJPPP.2024.v14.i12.5
- By:
- Publication type:
- Article
Advancing Materiovigilance in Dentistry: A Crucial Step for Patient Safety in India.
- Published in:
- JIDA: Journal of Indian Dental Association, 2024, v. 18, n. 10, p. 7
- By:
- Publication type:
- Article
Effect of Shengyang Yiwei Decoction combined with selective serotonin reuptake inhibitor antidepressants on HAMD-17 score and somatic symptoms in patients with depression.
- Published in:
- Pakistan Journal of Medical Sciences, 2025, v. 41, n. 1, p. 205, doi. 10.12669/pjms.41.1.9835
- By:
- Publication type:
- Article
Expanding Field of Dermatological Side Effects of Pharmaceuticals.
- Published in:
- Acta Dermato-Venereologica, 2024, v. 104, p. 1, doi. 10.2340/actadv.v104.42086
- By:
- Publication type:
- Article
Severe Acute Generalized Exanthematous Pustulosis Successfully Treated by Spesolimab.
- Published in:
- Acta Dermato-Venereologica, 2024, v. 104, p. 1, doi. 10.2340/actadv.v104.41311
- By:
- Publication type:
- Article
Novel Onset of Cutaneous Lupus Erythematosus Induced by Pembrolizumab.
- Published in:
- Acta Dermato-Venereologica, 2024, v. 104, p. 1, doi. 10.2340/actadv.v104.40801
- By:
- Publication type:
- Article
THE LEGAL FRAMEWORKS GOVERNING THE POST-MARKETING SURVEILLANCE OF PHARMACEUTICAL PRODUCTS AND THE MONITORING AND REPORTING OF ADVERSE DRUG REACTIONS (ADR).
- Published in:
- Biochemical & Cellular Archives, 2024, p. 3891, doi. 10.51470/bca.2024.24.1-S.3891
- By:
- Publication type:
- Article
Drug-induced cholestasis (DIC) predictions based on in vitro inhibition of major bile acid clearance mechanisms.
- Published in:
- Archives of Toxicology, 2025, v. 99, n. 1, p. 377, doi. 10.1007/s00204-024-03895-z
- By:
- Publication type:
- Article
Comparison of topical dapsone + tretinoin and clindamycin + tretinoin combination in terms of effectiveness in the treatment of mild and moderate acne vulgaris: a retrospective analysis.
- Published in:
- Archives of Dermatological Research, 2025, v. 317, n. 1, p. 1, doi. 10.1007/s00403-025-03825-8
- By:
- Publication type:
- Article
Drug-induced Parkinson-like events: a real-world study from 2004 to the first quarter of 2024 based on FAERS.
- Published in:
- Frontiers in Pharmacology, 2025, p. 1, doi. 10.3389/fphar.2024.1529260
- By:
- Publication type:
- Article
Exploring perceived barriers and attitudes in young adults towards antidepressant pharmacotherapy, including the implementation of pharmacogenetic testing to optimize prescription practices.
- Published in:
- Frontiers in Pharmacology, 2025, p. 1, doi. 10.3389/fphar.2024.1526101
- By:
- Publication type:
- Article
Synthesis, characterization, and computational evaluation of some synthesized xanthone derivatives: focus on kinase target network and biomedical properties.
- Published in:
- Frontiers in Pharmacology, 2025, p. 1, doi. 10.3389/fphar.2024.1511627
- By:
- Publication type:
- Article
Toxic epidermal necrolysis induced by nivolumab therapy for unresectable intraperitoneal cancer.
- Published in:
- Journal of Cutaneous Immunology & Allergy, 2025, p. 1, doi. 10.3389/jcia.2024.14014
- By:
- Publication type:
- Article
Ivonescimab Plus Chemotherapy in Patients With EGFR Variant Non–Small Cell Lung Cancer.
- Published in:
- 2025
- By:
- Publication type:
- Letter